Document Details

MGEN $0.50 $ - 0.06 (11.25%)
Document Details

Filing Type

8-K (SEC's EDGAR System)

Company Miragen Therapeutics (Boulder, CO)
Event Date 3/11/2020
Filing Date 3/11/2020

Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Results of Operations and Financial Condition and Financial Statements and Exhibits.

File Section(s)

  1. 8-K
  2. EX-99.1

Note: This document was filed with the SEC in HTML format, as allowed by the recent EDGAR system modernization. S&P cannot take responsibility for its appearance, layout, or legibility.